Searchable abstracts of presentations at key conferences in endocrinology

ea0035p733 | Neuroendocrinology | ECE2014

Prolactinemia and clinical outcome following second generation antipsychotics in early onset schizophrenia

Dobrescu Iuliana , Trutescu Carmen , Kobylinska Liana , Rad Florina , Petrescu-Ghenea Cristina , Anghel Gianina Cristina , Mihailescu Ilinca

Introduction: As antipsychotic drugs specifically block the D2 receptors, they induce a certain level of prolactin increase, dependent on the time it takes to dissociate from receptors. A recent review (Besnard et al, 2013) mentions that 18% of men and 47% of women treated with antipsychotics for severe mental illness had an increased prolactin level. Even if the long term effects of hyperprolactinemia can be severe, including low bone density, amenorrhea, breast and ...

ea0035p752 | Obesity | ECE2014

Adiponectin upregulates SHBG production: molecular mechanisms and potential implications

Simo Rafael , Lopez Cristina Saez , Lecube Albert , Hernandez Cristina , Fort Jose Manuel , Selva David M

Epidemiological studies have shown that plasma SHBG levels correlate with plasma adiponectin levels, both in men and women. To the best of our knowledge there are no reports describing any molecular mechanism by which adiponectin regulates hepatic SHBG production. The aim of the present study is to explore whether adiponectin regulates SHBG production by increasing HNF-4α levels through reducing hepatic lipid content. For this purpose, in vitro studies using huma...

ea0032p607 | Female reproduction | ECE2013

Main determinants of serum uric acid concentrations in polycystic ovary syndrome patients

Leustean Letitia , Preda Cristina , Ungureanu Maria Christina , Cristea Cristina , Mogos Voichita , Ungureanu Didona , Vulpoi Carmen

Introduction: Uric acid may increase cardiovascular risk, exerting proinflammatory, pro-oxidant and proliferative actions at the endothelial cell level. Classic and non-classic cardiovascular risk markers cluster in women with polycystic ovary syndrome (PCOS), uric acid being proposed as one of them. The studies available at present regarding serum uric acid levels in PCOS patients are scarce and controversial. The aim of the study was to examine the relationship between uric ...

ea0032p712 | Neuroendocrinology | ECE2013

Effects of GH therapy in carbohydrate metabolism in spanish adults with GH deficiency

Andrea Parra Ramirez Paola , Perez Fernandez Laura , Fernandez Martinez Alberto , Grande Aragon Cristina , Alvarez-Escola Cristina

GH deficiency (GHD) in adults is characterized by a tendency towards fat mass gain and may predispose to type 2 diabetes mellitus.GH replacement (GHR) is associated with impaired insulin sensitivity shortly after starting therapy, reflected by increased fasting glucose and insulin levels. Available evidence suggests that concerns regarding glucose intolerance in patients receiving long-term GHR have not been substantiated. However, several environmental and lifestyle-related f...

ea0032p732 | Obesity | ECE2013

Metabolic side effects of second generation antipsychotic drugs in adolescents

Dobrescu Iuliana , Rad Florina , Anghel Gianina Cristina , Petrescu-Ghenea Cristina , Trutescu Carmen

Introduction: Although for the last 2 decades we have witnessed a rise in the use of second generation antipsychotic treatment in children and adolescents suffering from psychiatric disorders we do not have enough studies in specialty literature to estimate the risks associated with this medication. Recent data and also our clinical experience shows that second generation antipsychotic drugs administration correlates with considerable weight gain and also with altering of gluc...

ea0014p180 | (1) | ECE2007

Lower catch-up growth under rGH therapy at pre-pubertal pituitary dwarves diagnosed at an older age

Branisteanu Dumitru , Galesanu Corina , Cristea Cristina , Zbranca Eusebie , Vulpoi Carmen , Preda Cristina , Mogos Voichita

Growth hormone deficiency leads to profoundly decreased growth velocity and, when untreated, to pituitary dwarfism. We evaluated growth evolution for one to four years under rGH therapy (0.07 IU/kg/day, subcutaneously) at seventeen idiopathic pituitary dwarves with isolated GH deficiency, 13 boys and 4 girls, with a wide span of age at therapy onset (between 4 and 24 years old). Diagnosis was set subsequent to at least two negative GH stimulation tests. All patients were pre-p...

ea0014p470 | (1) | ECE2007

Thyrotoxic hypokalemic periodic paralysis in two Caucasian females

Preda Cristina , Leustean Letitia , Vulpoi Carmen , Cristea Cristina , Ungureanu Christina , Zbranca Eusebie

Hypokalemic periodic paralysis is an uncommon complication of thyrotoxicosis especially in Caucasian women. It is most frequent in east asian and Japanese males and is characterized by recurrent episodes of motor weekness of variable intensity associated with hyperthyroidism. It is usually associated with low plasma potassium levels and is often precipitated by physical activity. This condition is a self limiting disorder that is cured by the treatment of the underlying hypert...

ea0014p500 | (1) | ECE2007

Short stature and neurofibromatosis type 1 – issues of diagnosis

Leustean Letitia , Hurjui Cristina , Preda Cristina , Vulpoi Carmen , Moisii Liliana , Zbranca Eusebie

Neurofibromatosis type 1 (NF1) is an inherited disorder characterized by formation of neurofibromas in the skin, brain and other parts of the body, in association with skin pigment changes. It is well known that this condition may be a risk factor for short stature with growth hormone deficiency (GHD) in children, due to suprasellar lesions. We present the case report of a 9-year-old boy admitted in our Service for short stature (-2DS). Physical examination revealed ‘caf&...

ea0056p1010 | Endocrine tumours and neoplasia | ECE2018

Thresholds of basal and calcium stimulated calcitonin for diagnosis of medullary thyroid carcinoma

Baetu Mara , Gheorghiu Cristina , Corneci Cristina , Ioachim Dumitru , Caragheorgheopol Andra , Dobrescu Ruxandra , Badiu Corin

Introduction: The current revised medullary thyroid carcinoma (MTC) guidelines don’t specify reference ranges of basal (bCT) or stimulated serum calcitonin (sCT) levels for the diagnosis of MTC. These are important for early diagnosis and correct management.Objective: We aimed to set gender specific thresholds for bCT and sCT for MTC diagnosis.Patients and methods: CT samples during calcium-stimulation test (2...

ea0073aep672 | Thyroid | ECE2021

Side-effects of calcitonin stimulation tests with calcium gluconate

Baetu Mara , Olariu Cristina , Nitu Ileana , Moldoveanu Gabriel , Corneci Cristina , Badiu Corin

IntroductionOver time, different substances and protocols have been used and tested for stimulating calcitonin (CT). Some of them proved to be useful in diagnosing medullary thyroid carcinoma (MTC). However, these are associated with side-effects, with various duration, intensity and severity.ObjectiveTo report the side-effects observed during CT stimulation test with calcium (Ca) gluconate.<p class="abst...